Eyenovia Inc. (NASDAQ: EYEN)
$0.0852
+0.0007 ( -0.70% ) 2.6M
Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.
Market Data
Open
$0.0852
Previous close
$0.0845
Volume
2.6M
Market cap
$9.29M
Day range
$0.0833 - $0.0863
52 week range
$0.0770 - $2.5700
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
def | Proxies and info statements | 4 | Dec 23, 2024 |
pre | Proxies and info statements | 3 | Dec 13, 2024 |
8-k | 8K-related | 13 | Dec 13, 2024 |
8-k | 8K-related | 22 | Dec 09, 2024 |
8-k | 8K-related | 20 | Nov 26, 2024 |
8-k | 8K-related | 15 | Nov 25, 2024 |
8-k | 8K-related | 13 | Nov 20, 2024 |
8-k | 8K-related | 15 | Nov 15, 2024 |
10-q | Quarterly Reports | 73 | Nov 12, 2024 |
8-k | 8K-related | 15 | Nov 12, 2024 |